Signaturefd, LLC Dbv Technologies S.A. Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$1.22 - $1.77 $2,032 - $2,948	-1,666 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$1.39 - $5.58 $2,193 - $8,805	1,578 Added 1793.18%	1,666 $3,000
Q3 2021 Oct 28, 2021	SELL	$4.71 - $5.92 $18 - $23	-4 Reduced 4.35%	88 $0
Q2 2021 Jul 26, 2021	BUY	$5.32 - $6.53 $489 - $600	92 New	92 $1,000
Q1 2019 May 09, 2019	SELL	$5.81 - $9.37 $11 - $18	-2 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$5.75 - $21.85 $11 - $43	2 New	2 $0
Q3 2018 Nov 15, 2018	SELL	$16.81 - $24.58 $50 - $73	-3 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$20.86 - $26.6 $62 - $79	3 New	3 $0

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $599M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.